Cargando…

Developing a preoperative serum metabolome-based recurrence-predicting nomogram for patients with resected pancreatic ductal adenocarcinoma

We investigated the potential application of preoperative serum metabolomes in predicting recurrence in patients with resected pancreatic cancer. From November 2012 to June 2014, patients who underwent potentially curative pancreatectomy for pancreatic ductal adenocarcinoma were examined. Among 57 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rho, Seoung Yoon, Lee, Sang-Guk, Park, Minsu, Lee, Jinae, Lee, Sung Hwan, Hwang, Ho Kyoung, Lee, Min Jung, Paik, Young-Ki, Lee, Woo Jung, Kang, Chang Moo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901525/ https://www.ncbi.nlm.nih.gov/pubmed/31819109 http://dx.doi.org/10.1038/s41598-019-55016-x

Ejemplares similares

Laparoscopic pancreaticoduodenectomy in pancreatic ductal adenocarcinoma
por: Choi, Munseok, et al.
Publicado: (2021)

Potential Impact of Phellinus linteus on Adherence to Adjuvant Treatment After Curative Resection of Pancreatic Ductal Adenocarcinoma: Outcomes of a Propensity Score–Matched Analysis
por: Lee, Sung Hwan, et al.
Publicado: (2018)

Clinical necessity of the immunohistochemical reassessment of para-aortic lymph nodes in resected pancreatic ductal adenocarcinoma
por: CHOI, SUNG HOON, et al.
Publicado: (2013)

Clinical Pattern of Preoperative Positron Emission Tomography/Computed Tomography (PET/CT) Can Predict the Aggressive Behavior of Resected Solid Pseudopapillary Neoplasm of the Pancreas
por: Kim, Ji-Su, et al.
Publicado: (2021)

Is Laparoscopic Pancreaticoduodenectomy Feasible for Pancreatic Ductal Adenocarcinoma?
por: Kang, Chang Moo, et al.
Publicado: (2020)

Intraoperative Transfusion is Independently Associated with a Worse Prognosis in Resected Pancreatic Cancer—A Retrospective Cohort Analysis
por: Kim, Si Youn, et al.
Publicado: (2020)

Novel Preoperative Nomogram for Prediction of Futile Resection in Patients Undergoing Exploration for Potentially Resectable Intrahepatic Cholangiocarcinoma
por: Nam, Kwangwoo, et al.
Publicado: (2017)

A nomogram to preoperatively predict 1-year disease-specific survival in resected pancreatic cancer following neoadjuvant chemoradiation therapy
por: Hwang, Ho Kyoung, et al.
Publicado: (2020)

Preoperative Metabolic Tumor Volume2.5 Associated with Early Systemic Metastasis in Resected Pancreatic Cancer: A Transcriptome-Wide Analysis
por: Lee, Sung Hwan, et al.
Publicado: (2019)

Preoperative Volume-Based PET Parameter, MTV(2.5), as a Potential Surrogate Marker for Tumor Biology and Recurrence in Resected Pancreatic Cancer
por: Kang, Chang Moo, et al.
Publicado: (2016)

An Updated Nomogram for Predicting Invasiveness in Preoperative Ductal Carcinoma In Situ of the Breast
por: Kim, Sanghwa, et al.
Publicado: (2019)

Preoperative Clinical and Computed Tomography (CT)-Based Nomogram to Predict Oncologic Outcomes in Patients with Pancreatic Head Cancer Resected with Curative Intent: A Retrospective Study
por: Hwang, Shin Hye, et al.
Publicado: (2019)

Development of a metabolite calculator for diagnosis of pancreatic cancer
por: Choi, Munseok, et al.
Publicado: (2023)

Preoperative prognostic nutritional index as an independent prognostic factor for resected ampulla of Vater cancer
por: Yoo, Young Jin, et al.
Publicado: (2020)

Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma
por: Cao, Ying-Ying, et al.
Publicado: (2023)

Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma
por: Bian, Yun, et al.
Publicado: (2022)

Prognostic Value of Sarcopenia and Myosteatosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Kim, Dong Wook, et al.
Publicado: (2022)

Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma
por: Hong, Sarang, et al.
Publicado: (2021)

Repeated Pancreatectomy for Isolated Local Recurrence in the Remnant Pancreas Following Radical Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Pooled Analysis
por: Choi, Munseok, et al.
Publicado: (2020)

Factors affecting long-term survival after surgical resection of pancreatic ductal adenocarcinoma
por: Yoon, Kyoung Won, et al.
Publicado: (2011)

Development and external validation of a radiomics combined with clinical nomogram for preoperative prediction prognosis of resectable pancreatic ductal adenocarcinoma patients
por: Wang, Fangqing, et al.
Publicado: (2022)

Laparoscopic repeated pancreatectomy for isolated local recurrence in remnant pancreas following laparoscopic radical pancreatectomy for pancreatic ductal adenocarcinoma: Two cases report
por: Choi, Munseok, et al.
Publicado: (2020)

Comparison of Characteristics and Survival Rates of Resectable Pancreatic Ductal Adenocarcinoma according to Tumor Location
por: Sung, Min Kyu, et al.
Publicado: (2021)

A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma
por: Gao, Jiahao, et al.
Publicado: (2020)

A case of pancreatic hamartoma pathologically confirmed after robot-assisted pancreaticoduodenectomy
por: Shin, Dong Hyun, et al.
Publicado: (2019)

A case of Wernicke's encephalopathy following complicated laparoscopic pylorus-preserving pancreaticoduodenectomy
por: Kim, Ji Su, et al.
Publicado: (2019)

Pancreaticoduodenectomy of Pancreatic Ductal Adenocarcinoma in the Elderly
por: Kang, Chang Moo, et al.
Publicado: (2007)

Preoperative CT Predicting Recurrence of Surgically Resected Adenocarcinoma of the Lung
por: Koo, Hyun Jung, et al.
Publicado: (2016)

Higher Tumor Cellularity in Resected Pancreatic Ductal Adenocarcinoma Is a Negative Prognostic Indicator
por: Cho, In Kuk, et al.
Publicado: (2020)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
por: Thakur, Gitika, et al.
Publicado: (2021)

Arterial resection during pancreatectomy for pancreatic ductal adenocarcinoma with arterial invasion: A single-center experience with 109 patients
por: Kwon, Jaewoo, et al.
Publicado: (2020)

Circulating tumour cells as an indicator of early and systemic recurrence after surgical resection in pancreatic ductal adenocarcinoma
por: Park, Yejong, et al.
Publicado: (2021)

Prognostic Significance of Maspin in Pancreatic Ductal Adenocarcinoma
por: Lim, Yun Jeong, et al.
Publicado: (2004)

Impact of radiologic splenic vessel invasion in resectable left-sided pancreatic ductal adenocarcinoma: predictor of early systemic recurrence following upfront surgery
por: Lee, Seung Jae, et al.
Publicado: (2022)

Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern
por: Kim, Hyoung Woo, et al.
Publicado: (2017)

The DPC4/SMAD4 genetic status determines recurrence patterns and treatment outcomes in resected pancreatic ductal adenocarcinoma: A prospective cohort study
por: Shin, Sang Hyun, et al.
Publicado: (2017)

Initial Metastatic Site as a Prognostic Factor in Patients With Stage IV Pancreatic Ductal Adenocarcinoma
por: Kim, Hyoung Woo, et al.
Publicado: (2015)

Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma
por: Kang, Sora, et al.
Publicado: (2022)

Pancreatic Ductal Adenocarcinoma at CT: A Combined Nomogram Model to Preoperatively Predict Cancer Stage and Survival Outcome
por: Cen, Chunyuan, et al.
Publicado: (2021)

A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection
por: He, Chaobin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mo8cu420ht8mc7ir3pnh8qungr